ATC Group: C01EB03 Indometacin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C01EB03 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C01 Cardiac therapy
3 C01E Other cardiac preparations
4 C01EB Other cardiac preparations
5 C01EB03 Indometacin

Active ingredients in C01EB03

Active Ingredient Description
Indometacin

Indometacin has anti-inflammatory, antipyretic, and analgesic effects, it is an inhibitor of prostaglandin synthetase.

Related product monographs

Title Information Source Document Type  
INDOCID Capsules Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
INDOCID Suppositories Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Austria (AT)

Brazil (BR)

Estonia (EE)

France (FR)

Hong Kong (HK)

Mexico (MX)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.